dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Couce, Maria Luz |
dc.contributor.author | Sánchez-Pintos, Paula |
dc.contributor.author | Aldámiz-Echevarría, Luís |
dc.contributor.author | Vitoria, Isidro |
dc.contributor.author | Navas-López, Víctor Manuel |
dc.contributor.author | Martín-Hernández, Elena |
dc.contributor.author | Pintos Morell, Guillem |
dc.date.accessioned | 2020-07-31T13:05:37Z |
dc.date.available | 2020-07-31T13:05:37Z |
dc.date.issued | 2019-09-01 |
dc.identifier.citation | Couce ML, Sánchez-Pintos P, Aldámiz-Echevarría L, Vitoria I, Navas V, Martín-Hernández E, et al. Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain. Medicine (Baltimore). 2019 Sep 1;98(39):e17303. |
dc.identifier.issn | 0025-7974 |
dc.identifier.uri | https://hdl.handle.net/11351/5130 |
dc.description | Nefrocalcinosi; Fenotip; Disfunció hepàtica greu |
dc.language.iso | eng |
dc.publisher | Wolters Kluwer Health, Inc. |
dc.relation.ispartofseries | Medicine;98(39) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Tiroide - Malalties |
dc.subject | Ciclohexà |
dc.subject | Qualitat de vida |
dc.subject.mesh | Tyrosinemias |
dc.subject.mesh | /complications |
dc.subject.mesh | Cyclohexanones |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Quality of Life |
dc.title | Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1097/MD.0000000000017303 |
dc.subject.decs | tirosinemias |
dc.subject.decs | /complicaciones |
dc.subject.decs | ciclohexanonas |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | calidad de vida |
dc.relation.publishversion | https://journals.lww.com/md-journal/FullText/2019/09270/Evolution_of_tyrosinemia_type_1_disease_in.66.aspx |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Couce ML, Sánchez-Pintos P] Unit of Diagnosis and Treatment of Congenital Metabolic Diseases, S. Neonatology, Department of Pediatrics, Clínico Universitario de Santiago de Compostela, Spain. CIBER de Enfermedades Raras (CIBERER), Madrid, Spain. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. [Aldámiz-Echevarría L] Unit of Metabolism, Department of Pediatrics, Hospital de Cruces, Baracaldo, Spain. Group of Metabolism, Biocruces Health Research Institute, Baracaldo, Spain. CIBER de Enfermedades Raras (CIBERER), Madrid, Spain. [Vitoria I] Unit of Metabolopathies, Hospital Universitario La Fe, Valencia, Spain. [Navas V] Pediatric Gastroenterology and Nutrition Unit Hospital Carlos Haya, Málaga, Spain. [Martín-Hernández E] Unit of Mitochondrial and Congenital Metabolic Diseases, Hospital 12 de Octubre, Madrid, Spain. [Pintos G] Unitat de Malalties Minoritàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 31574857 |
dc.identifier.wos | 000491346400066 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |